Cell microencapsulation is a promising approach to improve
cell
therapy outcomes by protecting injected cells from rapid dispersion
and allowing bidirectional diffusion of nutrients, oxygen, and waste
that promote cell survival in the target tissues. Here, we describe
a simple and scalable emulsification method to encapsulate animal
cells in chitosan microbeads using thermosensitive gel formulations
without any chemical modification and cross-linker. The process consists
of a water-in-oil emulsion where the aqueous phase droplets contain
cells (L929 fibroblasts or human mesenchymal stromal cells), chitosan
acidic solution and gelling agents (sodium hydrogen carbonate and
phosphate buffer or beta-glycerophosphate). The oil temperature is
maintained at 37 °C, allowing rapid physical gelation of the
microbeads. Alginate beads prepared with the same method were used
as a control. Microbeads with a diameter of 300–450 μm
were successfully produced. Chitosan and alginate (2% w/v) microbeads
presented similar rigidity in compression, but chitosan microbeads
endured >80% strain without rupture, while alginate microbeads
presented
fragile breakage at <50% strain. High cell viability and metabolic
activity were observed after up to 7 days in culture for encapsulated
cells. Mesenchymal stromal cells encapsulated in chitosan microbeads
released higher amounts of the vascular endothelial growth factor
after 24 h compared to the cells encapsulated in manually cast macrogels.
Moreover, microbeads were injectable through 23G needles without significant
deformation or rupture. The emulsion-generated chitosan microbeads
are a promising delivery vehicle for therapeutic cells because of
their cytocompatibility, biodegradation, mechanical strength, and
injectability. Clinical-scale encapsulation of therapeutic cells such
as mesenchymal stromal cells in chitosan microbeads can readily be
achieved using this simple and scalable emulsion-based process.